• Katharina Boehm, Stefani Ziewers, Maximilian P Brandt, Peter Sparwasser, Maximilian Haack, Franziska Willems, Anita Thomas, Robert Dotzauer, Thomas Höfner, Igor Tsaur, Axel Haferkamp, and Hendrik Borgmann.
• Department of Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany. Electronic address: katharina.boehm@unimedizin-mainz.de.
• Eur. Urol. 2020 Jul 1; 78 (1): 16-20.

The current coronavirus disease 2019 (COVID-19) pandemic has placed considerable strain on hospital resources. We explored whether telemedicine (defined as a videoconference) might help. We undertook prospective structured phone interviews of urological patients (n = 399). We evaluated their suitability for telemedicine (judged by a panel of four physicians) and their risks from COVID-19 (10 factors for a poor outcome), and collected willingness for telemedicine and demographic data. Risk factors for an adverse outcome from COVID-19 infection were common (94.5% had one or more) and most patients (63.2%) were judged suitable for telemedicine. When asked, 84.7% of patients wished for a telemedical rather than a face-to-face consultation. Those favouring telemedicine were younger (68 [58-75] vs 76 [70-79.2] yr, p < 0.001). There was no difference in preference with oncological (mean 86%) or benign diagnoses (mean 85%), or with COVID-19 risks factors. In subgroup analysis, men with prostate cancer preferred telemedicine (odds ratio: 2.93 [1.07-8.03], p = 0.037). We concluded that many urological patients have risk factors for a poor outcome from COVID-19 and most preferred telemedicine consultations at this time. This appears to be a solution to offer contact-free continuity of care. PATIENT SummaryRisk factors for a severe course of coronavirus disease 2019 are common (94.5%) in urology patients. Most patients wished for a telemedical consultation (84.7%). This appears to be a solution to offer contact-free continuity of care.Copyright © 2020. Published by Elsevier B.V.

31 keywords...

hide…